IBRX Stock Extends 3-Day Slide — Founder Teases New Trial In ‘Unstoppable’ Cancer-Treatment Push - Stocktwits
IBRX Stock Extends 3-Day Slide — Founder Teases New Trial In ‘Unstoppable’ Cancer-Treatment Push Stocktwits
IBRX Stock Extends 3-Day Slide — Founder Teases New Trial In ‘Unstoppable’ Cancer-Treatment Push Stocktwits
Breast cancer survivors could avoid lifelong heart medication, research suggests Medical Xpress
Many breast cancer survivors whose treatment caused them to develop problems with their heart function can safely stop their medication after their heart recovers, and most won't need to continue treatment long term, according to a study presented at the European Society of Cardiology Congress in Munich.
Men with prostate cancer have a high risk of heart disease, especially when treated with hormone therapy. A large international, first-of-its-kind study led by Hamilton researchers found that routine referrals to an internist or cardiologist improved cholesterol levels but did not lead to fewer heart attacks, strokes…
C/Can Advances Multidisciplinary Cancer Care in Concepción Oncodaily
C/Can Advances Multidisciplinary Cancer Care in Concepción Oncodaily
Juliana Cardoso: Congratulations to Clarissa Mathias Among 100 Influential Women in Oncology 2026 Oncodaily
Juliana Cardoso: Congratulations to Clarissa Mathias Among 100 Influential Women in Oncology 2026 Oncodaily
В США одобрили первый в своем классе RAS-ингибитор при метастатическом раке поджелудочной железы Naked Science
В США одобрили первый в своем классе RAS-ингибитор при метастатическом раке поджелудочной железы Naked Science
В США одобрили первый в своем классе RAS-ингибитор при метастатическом раке поджелудочной железы Naked Science
Новая вакцина от рака кожи прошла клинические испытания 24.kz
Новая вакцина от рака кожи прошла клинические испытания 24.kz
Гинцбург заявил об успешном лечении первого пациента вакциной от меланомы Дзен
Гинцбург заявил об успешном лечении первого пациента вакциной от меланомы Дзен